Article
Loss of P16INK4 expression is frequent in high grade gliomas.
Cancer research - 1 May 1995
Nishikawa R, Furnari F B, Lin H, Arap W, Berger M S, Cavenee W K, Su Huang H J
Abstract excerpt
P16INK4 is a cell cycle regulator that specifically binds to and inactivates cyclin-dependent kinase 4 (CDK4). Its encoding gene (p16/CDKN2) maps to chromosome 9p21, a region that undergoes frequent loss of heterozygosity in a variety of human tumors. We have analyzed the p16/CDKN2 gene and its expression in a series of primary glioma samples. Although homozygous deletion or mutation of the p16/CDKN2 gene was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
